Form 4 for EOG EOG Resources
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001127602-24-027962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-25 | 2024-11-21 | EOG | Yacob Ezra Y | COB, CEO, Dir | F - Tax | $136.00 | -2,190 | 179.3K | -1% | -$297.8K |
| DM | 2024-11-25 | 2024-11-21 | EOG | Yacob Ezra Y | COB, CEO, Dir | M - OptEx | $98.15 | +20.0K | 192.0K | +12% | +$1.96M |
| DM | 2024-11-25 | 2024-11-21 | EOG | Yacob Ezra Y | COB, CEO, Dir | D - Sale to Iss | $135.99 | -14.4K | 184.4K | -7% | -$1.96M |
| DM | 2024-11-25 | 2024-11-21 | EOG | Yacob Ezra Y | COB, CEO, Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-21 | F | D | 2,002 | $136.00 | 182,368.87 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-21 | M | A | 7,232 | $127.00 | 186,227.87 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-21 | D | D | 6,755 | $135.98 | 179,472.87 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-21 | M | A | 12,764 | $81.81 | 192,048.87 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-21 | F | D | 188 | $135.98 | 179,284.87 | D | — | — | |
| 6 | Common | Common Stock | 2024-11-21 | D | D | 7,678 | $136.00 | 184,370.87 | D | — | — | |
| 7 | Derivative | Stock Appreciation Rights | 2024-11-21 | M | D | 7,232 | $0.00 | 0 | D | $127.00 · 2021-09-27 to 2025-09-27 | 7,232 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. This exercise did not involve any open-market sale of the Issuer's Common Stock. |
| 8 | Derivative | Stock Appreciation Rights | 2024-11-21 | M | D | 12,764 | $0.00 | 0 | D | $81.81 · 2024-09-27 to 2028-09-27 | 12,764 Common Stock | (F2) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted became fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. |